PPT-Abuse Deterrent Opioids
Author : giovanna-bartolotta | Published Date : 2019-02-24
a Law enforcement perspective Charlie Cichon Executive Director The National Association of Drug Diversion Investigators NADDI The National Association of Drug Diversion
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Abuse Deterrent Opioids" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Abuse Deterrent Opioids: Transcript
a Law enforcement perspective Charlie Cichon Executive Director The National Association of Drug Diversion Investigators NADDI The National Association of Drug Diversion Investigators or NADDI is a nonprofit membership organization that works to develop and implement solutions to the problem of prescription drug diversion . The Child Ab use Prevention and Treatment Act CAPTA has these definitions Child abuse and neglect At a minimum any recent act or failure to act o n the part of a parent or caretaker which results in death serious physical or emotional harm sexual a Withdrawal 1991 Bush Admin Withdrawal 1992 Joint Declaration of the 1992 Joint Declaration of the Denuclearization of the Korean Peninsula Denuclearization of the Korean Peninsula Nuclear Extended Deterrence Nuclear Extended Deterrence brPage 4br Bob Twillman, Ph.D., FAPM. Executive . Director. American . Academy of Pain Management. Two Major Public Health Problems. Prescription . opioid abuse. :. 12.5 million non-medical users per year. $70-120 billion cost per year. Wayne Winegarden, Ph.D.. Sr. Fellow, Business & Economics, Pacific Research Institute. Contributing Editor, EconoSTATS a project of George Mason University. Partner, Capitol Economic Advisors. Presentation CWAG Annual Conference. Emerging knowledge and clinical experience. Conflict of Interest. None to declare. Objectives. Brief . overview of areas of emerging knowledge . F. acilitated discussion of clinical experiences and evolution . Prescription opioid abuse and the resurgence of heroin. Opioid Crisis Summit Meeting. October 17, . 2017. Dr. Theodore J. Cicero, PhD. Washington University in St. Louis,. Department of Psychiatry. Email: . Opiates bind to receptors in the brain, which means that they kill pain by preventing the transmission of pain impulses in the brain, rather than at the source.. Opiates are derived from opium, which is found in poppy seeds. . The Epidemic. Chronic Pain and Prescription Opioids. 11% of Americans experience daily (chronic) pain. Opioids frequently prescribed for chronic pain. Primary care providers commonly treat chronic, non-cancer pain. Performance: . A Review of Findings for the Medical . Review Board. July . 29, . 2014. Roadmap. Purpose. Background. Overview of Research Questions . Search Methodology . Q1a . Q1b . Q2 . Q3 . Conclusion. Saturday April 14, 2018. Kelly . Bossenbroek Fedoriw, MD. Opioid Crisis?. Kral LA, Jackson K, Uritsky T. A practical guide to tapering opioids. Ment Health Clin [Internet]. 2015;5(3):102-8. DOI: 10.9740/mhc.2015.05.102.. Joshua P. Cohen, PhD. Massachusetts State House. February 5, 2018. 20% of non-cancer pain patients are prescribed an . opioid. , compared to <5% in other industrialized nations. U.S. has 4% of the world’s population, yet 30% of global . Bureau of Health Care Safety and Quality. Department of Public Health. July 14, 2016. Review of June 2. nd. meeting. Non-Opioid Pain Management List. . Draft Formulary Guidance. Next Steps. Slide . Effectiveness and Value. Presentation to the Massachusetts Drug Formulary Commission. February 5, 2018. Presentation Agenda. Introduction to ICER. Comparative clinical effectiveness of abuse-deterrent formulations of opioids (ADFs). Immersion Training in Addiction Medicine Programs 2021. May 2021. Daniel P. Alford, MD, MPH. Professor of Medicine. Associate Dean, Continuing Medical Education. Director, Clinical Addiction Research and Education (CARE) Unit.
Download Document
Here is the link to download the presentation.
"Abuse Deterrent Opioids"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents